Arkolith/Insider Trading/ICVX/Form 4

Holtzman Douglas

Chief Scientific OfficerIcosavax, Inc. (ICVX) · full profile →Form 4 · filed Jul 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 3, 2023Sell(S)2K$9.59$20K290K
Jul 3, 2023Sell(S)14K$8.74$125K292K
Jul 3, 2023Option exercise(M)16K$1.04$17K306K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2023Option exercise(M)16K—$029K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-040716) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML